Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats

Cancer Chemotherapy and Pharmacology

Volumn 43, Issue 6, 1999, Pages 445-453

  Egorin, Merrill J ^a,b,d   Yuan, Zhi Min ^b   Sentz, Dorothy L ^b   Plaisance, Karen ^c   Eiseman, Julie L ^b,d  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Butyrate; Pharmacokinetics; Tributyrin

Indexed keywords

BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; TRIBUTYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL DIFFERENTIATION; COMPARTMENT MODEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GAS CHROMATOGRAPHY; HEMOGLOBINOPATHY; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC ACIDOSIS; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA HALF LIFE; PRIORITY JOURNAL; RAT; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; BUTYRATES; FEMALE; INJECTIONS, INTRAVENOUS; MICE; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 0032893270     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050922     Document Type: Article

References (39)

1. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19: 716
2. Boffa LC, Lupton JR, Mariani MR, Ceppi M, Newmark HL, Scalmati A, Lipkin M (1992) Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res 52: 5906
3. Bubley GJ, Kupiec N, Patierno SR, Xu J, Emi Y, Teicher BA (1995) Cisplatin-DNA adduct formation is markedly increased within nuclear matrix DNA and overall adduct formation is increased following arginine butyrate exposure. Proc Am Assoc Cancer Res 36: 290
4. Burns LJ, Glauber J, Ginder GD (1988) Butyrate induces selective transcriptional activation of a hypomethylated embryonic globin gene in adult erythroid cells. Blood 72: 1536
5. Chen ZX, Breitman TR (1994) Tributyrin: a prodrug of butyric acid for potential clinical application in differentiating therapy. Cancer Res 54: 3494
6. Clifford AJ, Smith LM, Creveling RK, Hamblin CL, Clifford CK (1986) Effects of dietary triglycerides on serum and liver lipids and sterol excretion in rats. J Nutr 116: 944
7. Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, Fram RJ, Van Echo DA (1998) Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 4: 629
8. Constantoulakis P, Papayannopoulou T, Stamatoyannopoulos G (1988) Alpha-amino-N-butyric acid stimulates fetal hemoglobin in the adult. Blood 72: 1961
9. Cordel S, Heyman MF, Boisteau O, Oliver L, Le Pendu J, Gregoire M, Meflah K (1997) 5-Fluorouracil-resistant colonic tumors are highly responsive to sodium butyrate/interleukin-2 bitherapy in rats. Int J Cancer 7: 924
10. Costin D, Dover G, Olivieri N, Beutler E, Wals CT, Torkelson S, Pantazis C, Brauer M, Faller DV, Perrine SP (1993) Clinical use of the butyrate derivative isobutyramide in the β-globin disorders. Blood 82: 357A
11. Daniel P, Braziek M, Cerutti I, Pieri F, Tardivel I, Desmet G, Baillets J, Chany C (1989) Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin Chim Acta 181: 255
12. D'Argenio DZ, Shumitzky A (1979) A program package for simulation and parameter estimation in pharmacokinetic systems. Comput Methods Programs Biomed 9: 115
13. Douillard JY, Perrin P, Gregoire M, Le Pendu J, Cordel S, Meflah K (1995) 5-Fluorouracil combined with sodium buty-rate has increased activity in rat colon carcinoma peritoneal carcinomatosis. Proc Am Assoc Cancer Res 36: 354
14. Dover GJ, Brusilow SW, Samid D (1992) Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate (letter). N Engl J Med 327: 569
15. Dover GJ, Brusilow SW, Charache S (1994) Induction of HbF production in subjects with sickle cell anemia by oral sodium phenybutyrate. Blood 84: 339
16. 1 mice. Cancer Chemother Pharmacol 8: 13
17. Emri S, Koc Y, O'Brien MC, Sanders D, Tansan S, Foss F (1994) Taxol and arginine butyrate exert additive antiproliferative effects on human mesothelioma cells. Proc Am Soc Clin Oncol 13: 130
18. Fibach E, Prasanna P, Rodgers GP, Samid D (1993) Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal blood donors and patients with sickle cell anemia and β-thalassemia. Blood 82: 2203
19. Foss F, O'Brien M, Bubley G, Galler D, Sanders D (1995) Biomodulatory effects of arginine butyrate: enhanced platinum-DNA-adduct formation. Proc Am Assoc Cancer Res 36: 291
20. Gibaldi M, Perrier D (1982) Nonlinear pharmacokinetics. In: Gibaldi M, Perrier D (eds) Pharmacokinetics. 2nd edn. Marcel Dekker, New York, p 271
21. Goto I, Yamamoto-Yamaguchi Y, Honma Y (1996) Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents. Br J Cancer 74: 546
22. Grasela TH Jr, Antal EJ, Townsend RJ, Smith RB (1986) An evaluation of population pharmacokinetics in therapeutic trials. I. Comparison of methodologies. Clin Pharmacol Ther 39: 605
23. 1H nuclear magnetic resonance spectroscopy. Lipids 31: 331
24. Kasukabe T, Rephaeli A, Honma Y (1997) An anti-cancer derivative of butyric acid (pivalyloxmethyl butyrate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells. Br J Cancer 75: 850
25. Ludden TM (1991) Nonlinear pharmacokinetics: clinical implications. Clin Pharmacokinet 20: 429
26. McDonagh KT, Nienhuis AW (1991) Induction of the human globin gene promotor in K562 cells by sodium butyrate; reversal of repression CCAAT displacement protein. Blood 78 [Suppl 1]: 255A
27. Mentzer SJ (1998) Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. Blood Cells Molecules Dis 24: 114
28. Miller AA, Kurschel E, Osieka R, Schmidt CG (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23: 1283
29. Novogrodsky A, Dvir A, Ravid A, Shkolnik T, Stenzel KH, Rubin AL, Zaizov R (1983) Effect of polar organic compounds on leukemic cells; butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer 51: 9
30. Perrine SP, Rudolph A, Faller DV, Roman C, Cohen RA, Chen S-J, Kan YW (1988) Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci USA 85: 8540
31. Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou TP (1989) Sodium butyrate enhances fetal globin expression in erythroid progenitors of patients with hemoglobin SS and β-thalassemia. Blood 74: 454
32. Perrine SP, Faller DV, Swerdlow P Sytkowski AJ, Qin G, Miller BA, Olivieri NF, Rudolph AM, Kan YW (1992) Pharmacologic prevention and reversal of globin gene switching. In: Stamatoyannopoulos G, Nienhuis AW (eds) The regulation of hemoglobin switching. Johns Hopkins University. Baltimore, Maryland, p 425
33. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowsha HE, Cai SP, Vichinsky EP, Olivieri NF (1993) A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N Engl J Med 328: 81
34. Pouillart P, Cerutti I, Ronco G, Villa P, Chany C (1992) Enhancement by stable butyrate derivatives of antitumor and antiviral actions of interferon. Int J Cancer 51: 596
35. Prasad KN (1980) Butyric acid: a small fatty acid with diverse biological functions. Life Sci 27: 1351
36. Rocci ML, Jusko WJ (1983) LAGRAN program for area and moments in pharmacokinetic analysis. Comput Methods Programs Biomed 16: 203
37. Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivieri NF (1995) Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N Engl J Med 332: 1606
38. Wasserman L, Beery E, Aviram R, Levavi H, Ovadia J, Novogrodsky A, Nordenberg J (1989) Sodium butyrate enhances the activities of membranal enzymes and increases drug sensitivity in a cell line from ascitic fluid of an ovarian cancer patient. Eur J Cancer Clin Oncol 25: 1765
39. Yeh KC, Kwan KC (1978) A comparison of numerical integrating algorithms by trapezoidal, LaGrange and Spline approximation. J Pharmacokinet Biopharm 6: 79